WOCKPHARMA.NS
Price:
$1351
Market Cap:
$219.53B
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, the United Kingdom, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules. The company's biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. It also provides c...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-07-01
Stock Exchange
NSE
Ticker
WOCKPHARMA.NS
According to Wockhardt Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1000.74. This represents a change of -2545.81% compared to the average of 40.92 of the last 4 quarters.
The mean historical PE Ratio of Wockhardt Limited over the last ten years is -57.69. The current -1000.74 PE Ratio has changed 173.36% with respect to the historical average. Over the past ten years (40 quarters), WOCKPHARMA.NS's PE Ratio was at its highest in in the December 2024 quarter at 389.24. The PE Ratio was at its lowest in in the September 2017 quarter at -512.75.
Average
-57.69
Median
-16.14
Minimum
-479.44
Maximum
43.19
Discovering the peaks and valleys of Wockhardt Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.47%
Maximum Annual PE Ratio = 43.19
Minimum Annual Increase = -279.54%
Minimum Annual PE Ratio = -479.44
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -479.44 | 2.47% |
| 2024 | -18.65 | 370.29% |
| 2023 | -3.97 | -69.55% |
| 2022 | -13.02 | -279.54% |
| 2021 | 7.25 | -124.21% |
| 2020 | -29.97 | 6.69% |
| 2019 | -28.09 | 106.18% |
| 2018 | -13.62 | -66.46% |
| 2017 | -40.61 | -194.03% |
| 2016 | 43.19 | -15.81% |
The current PE Ratio of Wockhardt Limited (WOCKPHARMA.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-167.35
5-year avg
-101.57
10-year avg
-57.69
Wockhardt Limited’s PE Ratio is less than Eris Lifesciences Limited (50.82), less than Eris Lifesciences Limited (50.82), less than AstraZeneca Pharma India Limited (115.00), less than AstraZeneca Pharma India Limited (115.00), less than Neuland Laboratories Limited (92.97), less than Neuland Laboratories Limited (92.97), less than Piramal Enterprises Limited (43.81), less than J. B. Chemicals & Pharmaceuticals Limited (39.77), less than J. B. Chemicals & Pharmaceuticals Limited (39.77), less than Alembic Pharmaceuticals Limited (28.02),
| Company | PE Ratio | Market cap |
|---|---|---|
| 50.82 | $211.42B | |
| 50.82 | $211.13B | |
| 115.00 | $229.05B | |
| 115.00 | $228.32B | |
| 92.97 | $223.25B | |
| 92.97 | $221.96B | |
| 43.81 | $254.86B | |
| 39.77 | $286.09B | |
| 39.77 | $285.69B | |
| 28.02 | $178.20B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wockhardt Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Wockhardt Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Wockhardt Limited's PE Ratio?
How is the PE Ratio calculated for Wockhardt Limited (WOCKPHARMA.NS)?
What is the highest PE Ratio for Wockhardt Limited (WOCKPHARMA.NS)?
What is the 3-year average PE Ratio for Wockhardt Limited (WOCKPHARMA.NS)?
What is the 5-year average PE Ratio for Wockhardt Limited (WOCKPHARMA.NS)?
How does the current PE Ratio for Wockhardt Limited (WOCKPHARMA.NS) compare to its historical average?